Double Medical Technology Statistics
Total Valuation
SHE:002901 has a market cap or net worth of CNY 15.65 billion. The enterprise value is 14.89 billion.
Market Cap | 15.65B |
Enterprise Value | 14.89B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
Earnings Date | Apr 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SHE:002901 has 406.61 million shares outstanding. The number of shares has decreased by -1.18% in one year.
Current Share Class | 406.61M |
Shares Outstanding | 406.61M |
Shares Change (YoY) | -1.18% |
Shares Change (QoQ) | -1.23% |
Owned by Insiders (%) | 85.43% |
Owned by Institutions (%) | 5.70% |
Float | 59.24M |
Valuation Ratios
The trailing PE ratio is 40.14 and the forward PE ratio is 31.05.
PE Ratio | 40.14 |
Forward PE | 31.05 |
PS Ratio | 6.93 |
PB Ratio | 4.73 |
P/TBV Ratio | 5.21 |
P/FCF Ratio | 74.92 |
P/OCF Ratio | 37.67 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.08, with an EV/FCF ratio of 71.27.
EV / Earnings | 37.40 |
EV / Sales | 6.59 |
EV / EBITDA | 30.08 |
EV / EBIT | 40.29 |
EV / FCF | 71.27 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.12.
Current Ratio | 3.21 |
Quick Ratio | 1.74 |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.79 |
Debt / FCF | 1.87 |
Interest Coverage | 62.57 |
Financial Efficiency
Return on equity (ROE) is 13.18% and return on invested capital (ROIC) is 6.17%.
Return on Equity (ROE) | 13.18% |
Return on Assets (ROA) | 5.09% |
Return on Invested Capital (ROIC) | 6.17% |
Return on Capital Employed (ROCE) | 10.36% |
Revenue Per Employee | 501,580 |
Profits Per Employee | 88,426 |
Employee Count | 4,503 |
Asset Turnover | 0.50 |
Inventory Turnover | 0.60 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.35% in the last 52 weeks. The beta is 0.14, so SHE:002901's price volatility has been lower than the market average.
Beta (5Y) | 0.14 |
52-Week Price Change | +21.35% |
50-Day Moving Average | 34.33 |
200-Day Moving Average | 31.15 |
Relative Strength Index (RSI) | 64.69 |
Average Volume (20 Days) | 3,168,694 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002901 had revenue of CNY 2.26 billion and earned 398.18 million in profits. Earnings per share was 0.96.
Revenue | 2.26B |
Gross Profit | 1.52B |
Operating Income | 369.69M |
Pretax Income | 480.56M |
Net Income | 398.18M |
EBITDA | 484.76M |
EBIT | 369.69M |
Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 1.26 billion in cash and 389.94 million in debt, giving a net cash position of 874.00 million or 2.15 per share.
Cash & Cash Equivalents | 1.26B |
Total Debt | 389.94M |
Net Cash | 874.00M |
Net Cash Per Share | 2.15 |
Equity (Book Value) | 3.31B |
Book Value Per Share | 7.85 |
Working Capital | 1.98B |
Cash Flow
In the last 12 months, operating cash flow was 415.56 million and capital expenditures -206.60 million, giving a free cash flow of 208.96 million.
Operating Cash Flow | 415.56M |
Capital Expenditures | -206.60M |
Free Cash Flow | 208.96M |
FCF Per Share | 0.51 |
Margins
Gross margin is 67.19%, with operating and profit margins of 16.37% and 17.63%.
Gross Margin | 67.19% |
Operating Margin | 16.37% |
Pretax Margin | 21.28% |
Profit Margin | 17.63% |
EBITDA Margin | 21.46% |
EBIT Margin | 16.37% |
FCF Margin | 9.25% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.30%.
Dividend Per Share | 0.50 |
Dividend Yield | 1.30% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 29.46% |
Buyback Yield | 1.18% |
Shareholder Yield | 2.48% |
Earnings Yield | 2.54% |
FCF Yield | 1.33% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SHE:002901 has an Altman Z-Score of 8.3.
Altman Z-Score | 8.3 |
Piotroski F-Score | n/a |